Oxurion NV — Major Shareholding Notification 2024

Apr 11, 2024

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities LLC

Leuven, BELGIË – 11 april 2024 – 19u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving¹ , de volgende transparantiekennisgevingen heeft ontvangen:

Oxurion ontving op 10 april 2024 een eerste transparantiekennisgeving van Atlas Special Opportunities LLC waaruit blijkt dat het op 1 april 2024 1.630.434.782 aandelen van de toen uitstaande 9.014.821.287 aandelen bezat en dus boven de drempel (15%) kwam door de verwerving van stemrechtverlenende effecten. Zie bijlage 1.

Oxurion ontving op 10 april 2024 een tweede transparantiekennisgeving van Atlas Special Opportunities LLC waaruit blijkt dat het op 8 april 2024 886.039.886 aandelen van de toen uitstaande 9.014.821.287 aandelen bezat en dus onder de drempel (10%) kwam door de verkoop van stemrechtverlenende effecten. Zie bijlage 2.

Over Oxurion

Oxurion (Euronext Brussel: OXUR) houdt zich bezig met de ontwikkeling van de volgende generatie standaard oftalmologische therapieën voor de behandeling van netvliesaandoeningen. Oxurion is gevestigd in Leuven, België. Meer informatie is beschikbaar op www.oxurion.com.

Belangrijke informatie over toekomstgerichte verklaringen

Bepaalde verklaringen in dit persbericht kunnen als "toekomstgericht" worden beschouwd. Dergelijke toekomstgerichte verklaringen zijn gebaseerd op de huidige verwachtingen en brengen dienovereenkomstig verschillende risico's en onzekerheden met zich mee en worden ze beïnvloed. Het bedrijf kan daarom geen enkele garantie geven dat dergelijke toekomstgerichte verklaringen zullen materialiseren en aanvaardt geen enkele verplichting om een toekomstgerichte verklaring bij te werken of te herzien, hetzij als gevolg van nieuwe informatie, toekomstige gebeurtenissen of enige andere reden. Aanvullende informatie over risico's en onzekerheden die van invloed zijn op het bedrijf en andere factoren die ertoe kunnen leiden dat de werkelijke resultaten wezenlijk verschillen van een toekomstgerichte verklaring, is opgenomen in het jaarverslag van het bedrijf. Dit persbericht vormt geen aanbod of uitnodiging voor de verkoop of aankoop van effecten of activa van Oxurion in enig rechtsgebied. Er mogen geen effecten van Oxurion worden aangeboden of verkocht in de Verenigde Staten zonder registratie onder de U.S. Securities Act van 1933, zoals gewijzigd, of in overeenstemming met een vrijstelling daarvan, en in overeenstemming met toepasselijke Amerikaanse effectenwetten.

Voor meer informatie kunt u contact opnemen met:

________

Oxurion NV	Backstage Communication
Pascal Ghoson	Jurgen Vluijmans
Chief Executive Officer	Partner
Pascal.ghoson@oxurion.com	jurgen@backstagecom.be

1. Artikel 14, eerste alinea, van de Wet van 2 mei 2007 betreffende de openbaarmaking van belangrijke deelnemingen.

BIJLAGE 1

uSign Envelope ID: 10CF68B5-0C1C 4A85-9417-56A33CD0572A

FSMA	FINANCIAL SERVICES AND MARKETS AUTHORITY	Form TR-1 BE PART I	Transparency notification
1) Status of the notification
	Final
2) Issuer
	Name OXURION
Identification number 0881-620-924
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4) Notification by
	A person that notifies alone
5) Persons subject to the notification requirement
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC		2500 Westchester Avenue, Suite 401, Purchase, NY 10577
	6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Address (for legal entities) Name
	Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6		Part II
7) Date on which the threshold is crossed
		01/04/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
15
	If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
9,014,821,287
	Please enter the denominator before filling in the data
10) Notified details
A) Voting rights	Previous notification		After the transaction
Holders of voting rights	# of voting rights	Linked to securities	# of voting rights Not linked to the	Linked to securities	% of voting rights Not linked to the
Atlas Special Opportunities LLC	0	1,630,434,782	securities	18.09%	securities
	TOTAL	1,630,434,782	0	18.09%	0.00%

1,630,434,782 1182 1182 118 118 18.09% 18.09% 18.09% 18.09% 118.09% 118.0 Start with "groups" of holders. Add subtotals with D, and then finish with the persons who are "alone".
For groups, start with the ultimate controlling natural person or leg

DocuSign Envolope ID: 10CF68B5 0C1C-4A85-9417-56A33CD9572A

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
	TOTAL			0	0.00%
3	The totals will be updated once you have clicked on
TOTAL (A & B)			# of voting rights	% of voting rights
			CALQUIATE	1,630,434,782	18.09%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

Atlas Special Opportunities LLC is not a controlled entity.

12) In case of proxy voting for only one GM

	will cease to hold /		(DD/MM/YYYY
Holder	will hold again	voting rights as of

13) Additional information

On 28 March 2024 (with settlement date on 1 April 2014) All 2012 stares in Operior NY, as a result of Wrich is shareholding decreased of (60,0,447 72 chares (= 18.09%, denominator = 9,014,821,287).

For security reasons, the unsigned form in xlsx format should be
transmitted to trg.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via the "

In addition, a signed copy in PDF format should also be
transmitted.

BIJLAGE 2

DocuSign Envolope ID: BEED37E6-F968-4E73-94E1-7D83B16E13F0

FSMA	FINANCIAL SERVICES AND MARKETS AUTHORITY		Form TR-1 BE PART I	Transparency notification
1) Status of the notification
	Final
2) Issuer
	Name OXURION
Identification number 0881-620-924
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4) Notification by
	A person that notifies alone
5) Persons subject to the notification requirement
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC		2500 Westchester Avenue, Suite 401, Purchase, NY 10577
6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Name	Address (for legal entities)
	Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6			Part II
7) Date on which the threshold is crossed
08/04/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
10
	If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
		9,014,821,287
	Please enter the denominator before filling in the data
10) Notified details
A) Voting rights	Previous notification	After the transaction
Holders of voting rights	# of voting rights		Linked to securities	# of voting rights Not linked to the	Linked to securities	% of voting rights Not linked to the
Atlas Special Opportunities LLC	1,630,434,782		886,039,886	securities	9.83%	securities

886,039,886
9.83% 9.83% Co Start with "groups" of holders. Add subtotals with Z, and then finish with the persons who are "alone".
For groups, start with the ultimate controlling natural person or

0.00%

TOTAL

DocuSign Envelope ID: BEED37E6-F968-4E73-94E1-7D83B16E13F0

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
	TOTAL			0	0.00%
11	The totals will be updated once you have clicked on
TOTAL (A & B)				# of voting rights	% of voting rights
			CALCULATE	886,039,886	9.83%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

Atlas Special Opportunities LLC is not a controlled entity.

12) In case of proxy voting for only one GM

			(DD/MM/YYYY
Holder	will cease to hold / will hold again	voting rights as of

13) Additional information

On 4 April 2024 (with settlement date on 8 April 2006) 14,394,394,394,394,394,394,394,394,399 shares in Oxumon NV, as a result of virich its shareholding decreased b 80,030,8 denominator = 9,014,821,287).

For security reasons, the unsigned form in xlsx format should be
transmitted to trg.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via the "

In addition, a signed copy in PDF format should also be
transmitted.